| Code | Age (years) | Sex | Diagnosis | Atopy | c-Jun staining* | Epithelial damage† | ||
| Before treatment | After treatment | Before treatment | After treatment | |||||
| Nasal polyposis | ||||||||
| NP1 | 37 | F | NP | − | 3 | 9 | 2 | 0 |
| NP2 | 52 | M | NP | + | 4 | 6 | 1 | 1 |
| NP3 | 18 | M | NP | + | 9 | 9 | 0 | 0 |
| NP4 | 55 | F | NP | + | 2 | 9 | 2 | 0 |
| NP5 | 32 | M | NP | + | 6 | 9 | 2 | 0 |
| NP6 | 48 | F | NP | + | 4 | 9 | 1 | 0 |
| NP7 | 34 | M | NP | + | 9 | 9 | 1 | 0 |
| NP8 | 55 | M | NP | + | 9 | 9 | 0 | 0 |
| NP9 | 30 | M | NP | − | 4 | 9 | 1 | 0 |
| NP10 | 24 | M | NP | + | 4 | 9 | 1 | 1 |
| Nasal mucosal controls | ||||||||
| IT1 | 26 | M | SD | − | NA | NA | NA | NA |
| IT2 | 36 | F | SD | − | 9 | NA | 0 | NA |
| IT3 | 29 | M | SD | − | 9 | NA | 0 | NA |
| IT4 | 23 | F | SD | + | 9 | NA | 0 | NA |
| IT5 | 33 | M | SD | − | 9 | NA | 0 | NA |
| IT6 | 27 | M | SD | + | 9 | NA | 0 | NA |
NA, not applicable.
*c-Jun staining is described in the online supplement; overall score obtained by multiplying the extent score (0–3) by the intensity score (0–3).
†Epithelium evaluation as described in the online supplement: 0, intact epithelium; 1, moderately damaged epithelium; 2, severely damaged epithelium.